Related Articles
Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma (Review)
A mutation in the common docking domain of ERK2 in a human cancer cell line, which was associated with its constitutive phosphorylation
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines